Daiken Biomedical Co., Ltd. (TPE:7780)
24.20
-0.20 (-0.82%)
At close: Feb 11, 2026
33.33% (1Y)
| Market Cap | 19.60B +84.6% |
| Revenue (ttm) | 1.78B +42.7% |
| Net Income | 268.63M +116.5% |
| EPS | 0.44 +21.6% |
| Shares Out | 810.02M |
| PE Ratio | 55.39 |
| Forward PE | 46.01 |
| Dividend | 0.40 (1.67%) |
| Ex-Dividend Date | Nov 24, 2025 |
| Volume | 4,776,316 |
| Average Volume | 16,119,930 |
| Open | 24.40 |
| Previous Close | 24.40 |
| Day's Range | 24.00 - 24.50 |
| 52-Week Range | 14.65 - 40.10 |
| Beta | n/a |
| RSI | 52.14 |
| Earnings Date | Apr 23, 2026 |